Abstract
The COVID-19 pandemic has significantly impacted on the delivery of clinical trials in the UK, posing complicated organisational challenges and requiring adaptations, especially to exercise intervention studies based in the community. We aim to identify the challenges of public involvement, recruitment, consent, follow-up, intervention and the healthcare professional delivery aspects of a feasibility study of exercise in hypertensive primary care patients during the COVID-19 pandemic. While these challenges elicited many reactive changes which were specific to, and only relevant in the context of ‘lockdown’ requirements, some of the protocol developments that came about during this unprecedented period have great potential to inform more permanent practices for carrying out this type of research. To this end, we detail the necessary adaptations to many elements of the feasibility study and critically reflect on our approach to redesigning and amending this ongoing project in order to maintain its viability to date. Some of the more major protocol adaptations, such as moving the study to remote means wherever possible, had further unforeseen and undesirable outcomes (eg, additional appointments) with regards to extra resources required to deliver the study. However, other changes improved the efficiency of the study, such as the remote informed consent and the direct advertising with prescreening survey. The adaptations to the study have clear links to the UK Plan for the future of research delivery. It is intended that this specific documentation and critical evaluation will help those planning or delivering similar studies to do so in a more resource efficient and effective way. In conclusion, it is essential to reflect and respond with protocol changes in the current climate in order to deliver clinical research successfully, as in the case of this particular study.
Reference25 articles.
1. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
2. National Institute for Health and Care Research (NIHR) . Restart framework - A framework for restarting NIHR research activities which have been paused due to COVID-19; Available: https://www.nihr.ac.uk/documents/restart-framework/24886?pr= [Accessed 01 Feb 2021].
3. The World of Clinical Trial Development Post COVID-19: Lessons Learned from a Global Pandemic
4. Medidata . COVID-19 and clinical trials: the medidata perspective; Available: https://www.medidata.com/wp-content/uploads/2020/07/COVID19-Response7.0_Clinical-Trials_2020729_v1.pdf
5. Health Research Authority (HRA) . Making changes to a research study to manage the impact of covid-19; Available: https://www.hra.nhs.uk/covid-19-research/covid-19-guidance-sponsors-sites-and-researchers/# [Accessed 01 Feb 2021].
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献